Methods |
Study design: open‐label, active comparator, parallel RCT
Duration of study: June 2007 to January 2009
Duration of follow‐up: 1 year
|
Participants |
Country: Switzerland
Setting: single centre
Inclusion criteria: kidney transplant recipients (age 18 to 65 years) between 3 months and 8 years post transplant (live donor); venous serum bicarbonate < 24 mmol/L; eGFR > 30 mL/min/1.73 m2
Number: treatment group (19); control group (11)
Mean age ± SD (years): treatment group (48 ± 12); control group (48 ± 8)
Sex (M/F): treatment group (15/4); control group (11/0)
Exclusion criteria: acute rejection episodes; severe physical limitation; psychiatric disorder; malignancy; catabolic state due to systemic illness; acute systemic infection; pregnancy
|
Interventions |
Treatment group
Control group
Co‐interventions
|
Outcomes |
Change in serum calcium, phosphate, iPTH, alkaline phosphatase, vitamin D and biomarkers of bone turnover
Change in BMD at lumbar spine, total hip, femoral neck, and non‐dominant forearm (total and distal radius)
|
Notes |
Funding source: Scientific grants from the Swiss National Science Foundation (3200B0‐112299) and the Hermann Klaus Foundation (Zurich, Switzerland). All study medication was provided by Vifor (Fribourg, Switzerland)
|
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Random sequence generation (selection bias) |
Unclear risk |
Insufficient information to permit judgement |
Allocation concealment (selection bias) |
Unclear risk |
Insufficient information to permit judgement |
Blinding of participants and personnel (performance bias)
All outcomes |
Unclear risk |
Insufficient information to permit judgement |
Blinding of outcome assessment (detection bias)
All outcomes |
Unclear risk |
Insufficient information to permit judgement |
Incomplete outcome data (attrition bias)
All outcomes |
Unclear risk |
Insufficient information to permit judgement |
Selective reporting (reporting bias) |
High risk |
Patient important outcomes not captured or reported systematically |
Other bias |
High risk |
Imbalances in gender and duration of transplantation between treatment groups at baseline |